AR and Familial prostate cancer: New curcumin analogs from other research groups [84-86] are also being evaluated for cytotoxic activity against two human prostate cancer cell lines, i.e. LNCaP and PC-3, and inhibitory activity to the AR, with goals to elucidate more refined SAR and optimize curcumin analogs to develop better anti-prostate cancer drugs.